Covetrus Inc
Change company Symbol lookup
Select an option...
CVET Covetrus Inc
LION Fidelity Southern Corp
IMGN ImmunoGen Inc
BEN Franklin Resources Inc
BAC Bank of America Corp
EVH Evolent Health Inc
EEA The European Equity Fund Inc
BSTG Biostage Inc
UTX United Technologies Corp
USG USG Corp
Go

Company profile

Covetrus, Inc. is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. It combines practice management software, prescription management, multi-channel client engagement services and supply chain infrastructure to promote connectivity between veterinarians and clients. The Company is also focused on providing inventory management, specialty pharmacy services, solutions to chronic care disease management, veterinary practice management software and client communication tools.

Closing Price
$32.65
Day's Change
-0.31 (-0.94%)
Bid
--
Ask
--
B/A Size
--
Day's High
33.34
Day's Low
32.26
Volume
(Below Average)
Volume:
720,260

10-day average volume:
825,112
720,260
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2019. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.